| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |